Frances Rosario Bonnin Serralles, AUD | |
1514 Jefferson Hwy, New Orleans, LA 70121-2429 | |
(866) 624-7637 | |
Not Available |
Full Name | Frances Rosario Bonnin Serralles |
---|---|
Gender | Female |
Speciality | Audiologist |
Location | 1514 Jefferson Hwy, New Orleans, Louisiana |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386381705 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
231H00000X | Audiologist | (* (Not Available)) | Primary |
Provider Name | Ochsner Clinic Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
As many cancer patients will confirm, the chemotherapy prescribed to kill the disease is often more debilitating than the cancer itself, with a range of horrendous side effects.
Access Pharmaceuticals, Inc., today announced it has initiated a Phase I/II dose-escalating study of its proprietary, anti-cancer drug, Thiarabine, a nucleoside analog for patients with hematologic malignancies (cancers of the blood). The primary objective of the study is to determine the maximum tolerated dose (MTD) in two different dosing schedules with various leukemias and lymphomas and recommended Phase II dose. The program is being led by Hagop Kantarjian, M.D., Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center in Houston, Texas.
Response Genetics, Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, announced today four presentations to be held during the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL from June 1 to June 5, 2012. Study results are based on the company's proprietary technology and approach.
Several states are likely dramatically underestimating the effect of opioid-related deaths because of incomplete death certificate reporting, with Pennsylvania leading the pack, according to a new analysis by the University of Pittsburgh Graduate School of Public Health.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Frances Rosario Bonnin Serralles, AUD 1514 Jefferson Hwy, New Orleans, LA 70121-2429 Ph: () - | Frances Rosario Bonnin Serralles, AUD 1514 Jefferson Hwy, New Orleans, LA 70121-2429 Ph: (866) 624-7637 |
News Archive
As many cancer patients will confirm, the chemotherapy prescribed to kill the disease is often more debilitating than the cancer itself, with a range of horrendous side effects.
Access Pharmaceuticals, Inc., today announced it has initiated a Phase I/II dose-escalating study of its proprietary, anti-cancer drug, Thiarabine, a nucleoside analog for patients with hematologic malignancies (cancers of the blood). The primary objective of the study is to determine the maximum tolerated dose (MTD) in two different dosing schedules with various leukemias and lymphomas and recommended Phase II dose. The program is being led by Hagop Kantarjian, M.D., Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center in Houston, Texas.
Response Genetics, Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, announced today four presentations to be held during the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL from June 1 to June 5, 2012. Study results are based on the company's proprietary technology and approach.
Several states are likely dramatically underestimating the effect of opioid-related deaths because of incomplete death certificate reporting, with Pennsylvania leading the pack, according to a new analysis by the University of Pittsburgh Graduate School of Public Health.
› Verified 8 days ago
Vaughn Johnson Davis, AUD, CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4301 Tulane Ave Apt 275, New Orleans, LA 70119 Phone: 504-296-4834 | |
Miss Christine Elizabeth Gibson, M.C.D., CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 6260 Providence Pl, New Orleans, LA 70126 Phone: 504-957-7762 | |
Dr. Erica Cardosi, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 1900 Gravier St, New Orleans, LA 70112 Phone: 504-568-4343 | |
Mrs. Kristen Schexnayder, M.C.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 120 N Jefferson Davis Pkwy, New Orleans, LA 70119 Phone: 504-821-0244 | |
Elizabeth Nichole Brown, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-4565 | |
Dr. Danielle Dionne Mercer, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 533 Bolivar St Rm 659, New Orleans, LA 70112 Phone: 504-568-2435 | |
Dr. Madden Elizabeth Wilbert, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 866-624-7637 |